Evidence map›Paper›PMID 32722661›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2021

Dose-response effects of d-amphetamine on effort-based decision-making and reinforcement learning.

Heather E Soder, Jessica A Cooper, Paula Lopez-Gamundi, Jennifer K Hoots, Cecilia Nunez, Victoria M Lawlor, Scott D Lane, Michael T Treadway, Margaret C Wardle

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07664631 (Effects of Stimulant Medications in PTSD), which is not on this map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07664631 phase1not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Effects of Stimulant Medications in PTSD

TypeinterventionalSponsorUniversity of ChicagoRan2026 to 2027Enrolled40ConditionsAdderall, PTSD, Post Traumatic Stress DisorderArmsPlacebo, Adderall
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Lost in translation: why don't dopamine D2 antagonists cure addictions?Journal of psychiatry & neuroscience : JPN · 2026
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Amphetamines Improve the Motivation to Invest Effort in Attention-Deficit/Hyperactivity Disorder.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Heather E SoderFaillace Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
Jessica A CooperDepartment of Psychology, Emory University, Atlanta, GA, 30322, USA.
Paula Lopez-GamundiFaillace Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
Jennifer K HootsDepartment of Psychology, University of Illinois at Chicago, Chicago, 60607, IL, USA.
Cecilia NunezDepartment of Psychology, University of Illinois at Chicago, Chicago, 60607, IL, USA.
Victoria M LawlorDepartment of Psychology, Emory University, Atlanta, GA, 30322, USA.
Scott D LaneFaillace Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
Michael T TreadwayDepartment of Psychology, Emory University, Atlanta, GA, 30322, USA. mtreadway@emory.edu.
Margaret C WardleDepartment of Psychology, University of Illinois at Chicago, Chicago, 60607, IL, USA. mwardle@uic.edu.
Emory University · USThe University of Texas Health Science Center at Houston · USUniversity of Illinois Chicago · US

Funding

Dynamics of Inflammation and its Blockade on Motivational Circuitry in DepressionR01MH108605 · NIMH · EMORY UNIVERSITY · PI TREADWAY, MICHAEL TILGHMAN · 2016 to 2020
$2.1M
Targeting Anhedonia in Cocaine Use DisorderK08DA040006 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI WARDLE, MARGARET · 2016 to 2020
$842k
Stress and MDD effects on mPFC Glutamate and GABA during reward processingR00MH102355 · NIMH · EMORY UNIVERSITY · PI TREADWAY, MICHAEL TILGHMAN · 2015 to 2017
$733k
Motivational anhedonia: neurocomputational mechanisms and temporal dynamicsF32MH115692 · NIMH · EMORY UNIVERSITY · PI ROBINSON, JESSICA COOPER · 2018 to 2021
$218k
Using event-related potentials to predict treatment outcomes in cocaine use disorderF32DA048542 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI WEBBER, HEATHER E · 2020 to 2021
$134k
"la Caixa" Foundation (Caixa Foundation) LCF/BQ/DI19/11730047NIDA NIH HHS F32 DA048542NIDA NIH HHS K08 DA040006NIMH NIH HHS F32 MH115692NIMH NIH HHS R00 MH102355NIMH NIH HHS R01 MH108605U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) F32MH115692U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R00MH105305U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH108605U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) F32DA048542
6 · The paper itself

Abstract

Effort-related decision-making and reward learning are both dopamine-dependent, but preclinical research suggests they depend on different dopamine signaling dynamics. Therefore, the same dose of a dopaminergic medication could have differential effects on effort for reward vs. reward learning. However, no study has tested how effort and reward learning respond to the same dopaminergic medication within subjects. The current study aimed to test the effect of therapeutic doses of d-amphetamine on effort for reward and reward learning in the same healthy volunteers. Participants (n = 30) completed the Effort Expenditure for Reward Task (EEfRT) measure of effort-related decision-making, and the Probabilistic Reward Task (PRT) measure of reward learning, under placebo and two doses of d-amphetamine (10 mg, and 20 mg). Secondarily, we examined whether the individual characteristics of baseline working memory and willingness to exert effort for reward moderated the effects of d-amphetamine. d-Amphetamine increased willingness to exert effort, particularly at low to intermediate expected values of reward. Computational modeling analyses suggested this was due to decreased effort discounting rather than probability discounting or decision consistency. Both baseline effort and working memory emerged as moderators of this effect, such that d-amphetamine increased effort more in individuals with lower working memory and lower baseline effort, also primarily at low to intermediate expected values of reward. In contrast, d-amphetamine had no significant effect on reward learning. These results have implications for treatment of neuropsychiatric disorders, which may be characterized by multiple underlying reward dysfunctions.

Indexed as

DextroamphetamineMotivationDecision MakingHumansReinforcement, PsychologyRewardDextroamphetamine

Identifiers

PMID32722661
PMCPMC8115674
OpenAlexW3045658886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.